VERICI DX PLC

Verici Dx’s share price dips amid niche immuno‑diagnostics, yet offers a potential entry point for long‑term investors eyeing NHS partnerships and expanding personalized medicine.

Verici Dx Plc: Flat 0% move, £0.23 share price, 4.55% monthly rise, and 200‑day SMA at £0.43 – key data for UK immuno‑diagnostics investors.